TrueBlue (TBI)
(Delayed Data from NYSE)
$6.89 USD
-0.11 (-1.57%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $6.90 +0.01 (0.15%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for TrueBlue, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,906 | 2,254 | 2,174 | 1,846 | 2,369 |
Cost Of Goods | 1,400 | 1,652 | 1,613 | 1,406 | 1,743 |
Gross Profit | 506 | 602 | 560 | 441 | 626 |
Selling & Adminstrative & Depr. & Amort Expenses | 530 | 530 | 492 | 616 | 560 |
Income After Depreciation & Amortization | -24 | 72 | 68 | -175 | 66 |
Non-Operating Income | 3 | 1 | 5 | 2 | 7 |
Interest Expense | 0 | 0 | 0 | 0 | 3 |
Pretax Income | -21 | 73 | 74 | -173 | 70 |
Income Taxes | -6 | 11 | 12 | -31 | 7 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | 62 | 62 | -142 | 63 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | 62 | 62 | -142 | 63 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11 | 101 | 96 | 32 | 104 |
Depreciation & Amortization (Cash Flow) | 35 | 29 | 28 | 207 | 38 |
Income After Depreciation & Amortization | -24 | 72 | 68 | -175 | 66 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 31.32 | 33.45 | 35.43 | 35.37 | 39.18 |
Diluted EPS Before Non-Recurring Items | 0.28 | 2.43 | 2.00 | 0.43 | 2.05 |
Diluted Net EPS (GAAP) | -0.45 | 1.86 | 1.74 | -4.01 | 1.61 |
Fiscal Year end for TrueBlue, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 382.36 | 396.23 | 402.85 | 492.17 | 473.20 |
Cost Of Goods | 282.32 | 291.81 | 303.47 | 363.89 | 349.02 |
Gross Profit | 100.04 | 104.42 | 99.39 | 128.28 | 124.17 |
SG&A, R&D, and Dept/Amort Expenses | 106.94 | 164.39 | 114.90 | 136.91 | 126.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | -6.90 | -59.97 | -15.51 | -8.63 | -2.73 |
Non-Operating Income | 0.52 | 1.74 | 1.60 | 1.22 | 0.39 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -6.38 | -58.22 | -13.91 | -7.40 | -2.34 |
Income Taxes | 1.25 | 46.49 | -12.21 | -4.85 | -2.33 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.64 | -104.71 | -1.70 | -2.55 | -0.01 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.64 | -104.71 | -1.70 | -2.55 | -0.01 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 29.70 | 30.35 | 31.10 | 31.08 | 30.93 |
Diluted EPS Before Non-Recurring Items | -0.11 | -0.35 | 0.03 | 0.08 | 0.16 |
Diluted Net EPS (GAAP) | -0.26 | -3.45 | -0.05 | -0.08 | 0.00 |